Nathan Spangler

Nathan Spangler is a seasoned professional in the life sciences industry, currently serving as the Senior Director of Product Strategy & Innovation at Aldevron since April 2016, where responsibilities include building the IVT mRNA services platform to support groundbreaking therapies and vaccines. Previous experience includes roles as Director of Business Development at Scarab Genomics, where commercial operations and grant applications were advanced, and Director of Protein Services at Aldevron, focusing on recombinant antibody and protein business development. Earlier positions include Senior Business Development Manager at EMD Chemicals, Business Development Manager at Gentel Biosciences, and Senior Scientist at Caden Biosciences. Nathan began a career in the industry as a Scientist at PanVera, transitioning through various roles at Vertex Pharmaceuticals and Life Technologies, demonstrating a consistent focus on the development and commercialization of biotechnological solutions. Nathan holds a Ph.D. in Biochemistry from the University of Wisconsin-Madison and a BS in Chemistry from The University of Tennessee at Chattanooga.